Cargando…
New Opportunities in Glycan Engineering for Therapeutic Proteins
Glycans as sugar polymers are important metabolic, structural, and physiological regulators for cellular and biological functions. They are often classified as critical quality attributes to antibodies and recombinant fusion proteins, given their impacts on the efficacy and safety of biologics drugs...
Autores principales: | Zhong, Xiaotian, D’Antona, Aaron M., Scarcelli, John J., Rouse, Jason C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788452/ https://www.ncbi.nlm.nih.gov/pubmed/35076453 http://dx.doi.org/10.3390/antib11010005 |
Ejemplares similares
-
A potential antibody repertoire diversification mechanism through tyrosine sulfation for biotherapeutics engineering and production
por: Zhong, Xiaotian, et al.
Publicado: (2022) -
Recent Advances in the Molecular Design and Applications of Multispecific Biotherapeutics
por: Zhong, Xiaotian, et al.
Publicado: (2021) -
Identifying and managing refractory migraine: barriers and opportunities?
por: D’Antona, Linda, et al.
Publicado: (2019) -
Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
por: Wang, Wenyue, et al.
Publicado: (2019) -
Resources and Methods for Engineering “Designer” Glycan-Binding Proteins
por: Warkentin, Ruben, et al.
Publicado: (2021)